てんかん患者（16歳以上80歳未満）を対象としたブリバラセタムの有効性と安全性を評価する研究

基本情報

NCT ID: NCT03083665
ステータス: 完了
試験のフェーズ: 第3相
試験タイプ: 介入
目標被験者数: 449
治験依頼者名: UCB Pharma

概要

The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) compared to placebo (PBO) as adjunctive treatment in subjects (\>=16 to 80 years of age) with partial seizures with or without secondary generalization despite current treatment with 1 or 2 concomitant antiepileptic drugs (AEDs) and to assess the safety and tolerability of BRV in subjects \>= 16 years to 80 years of age.

対象疾患

Partial Seizures With or Without Secondary GeneralizationEpilepsy

介入

Placebo(DRUG)

Brivaracetam(DRUG)

依頼者（Sponsor）

ユーシービージャパン(INDUSTRY)

実施施設 (40)

Ep0083 102

Kagoshima, Japan

Ep0083 109

Yamagata, Japan

Ep0083 150

Yokohama, Japan

Ep0083 111

Hamamatsu, Japan

Ep0083 114

Saitama, Japan

Ep0083 148

Adachi-ku, Japan

Ep0083 136

Nagoya, Japan

Ep0083 118

Nagoya, Japan

Ep0083 108

Suita, Japan

Ep0083 104

Shizuoka, Japan

Ep0083 101

Sapporo, Japan

Ep0083 133

Ushiku, Japan

Ep0083 146

Chiba, Japan

Ep0083 147

Kyoto, Japan

Ep0083 127

Bunkyō City, Japan

Ep0083 141

Higashisonogi-gun Kawatana-cho, Japan

Ep0083 131

Ōtsu, Japan

Ep0083 142

Kamakura, Japan

Ep0083 132

Kōriyama, Japan

Ep0083 112

Kōshi, Japan

Ep0083 129

Neyagawa, Japan

Ep0083 122

Hachinohe, Japan

Ep0083 144

Shinjuku-ku, Japan

Ep0083 106

Niigata, Japan

Ep0083 130

Ôsaka, Japan

Ep0083 103

Sendai, Japan

Ep0083 121

Itami, Japan

Ep0083 128

Kurume, Japan

Ep0083 120

Yokohama, Japan

Ep0083 138

Tsukuba, Japan

Ep0083 140

Kawasaki, Japan

Ep0083 123

Kodaira, Japan

Ep0083 117

Nara, Japan

Ep0083 137

Suita, Japan

Ep0083 110

Hiroshima, Japan

Ep0083 124

Kyoto, Japan

Ep0083 126

Bunkyō City, Japan

Ep0083 105

Nagakute, Japan

Ep0083 116

Asaka, Japan

Ep0083 115

Kokubunji, Japan